ADLR Insider Trading Activity and SEC Form 4 Filings
ADLR insider trading summary
No open-market insider purchases or sales of Adolor Corp (ADLR) have been reported on SEC Form 4 in the past 12 months.
Latest ADLR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2011 | Cubist Pharmaceuticals Inc | 10% Owner | Buy | $33.6M (7,908,727 @ $4.25) |
| Dec 12, 2011 | FRD Acquisition Corp | 10% Owner | Buy | $33.6M (7,908,727 @ $4.25) |
| Dec 9, 2011 | Cubist Pharmaceuticals Inc | 10% Owner | Buy | $7.3M (1,729,130 @ $4.25) |
| Dec 9, 2011 | FRD Acquisition Corp | 10% Owner | Buy | $7.3M (1,729,130 @ $4.25) |
| Dec 9, 2011 | Cubist Pharmaceuticals Inc | 10% Owner | Buy | $214.5M (45,070,030 @ $4.76) |
| Dec 9, 2011 | FRD Acquisition Corp | 10% Owner | Buy | $214.5M (45,070,030 @ $4.76) |
| Dec 8, 2011 | FRD Acquisition Corp | 10% Owner | Buy | $5.0M (1,180,983 @ $4.25) |
| Dec 8, 2011 | Cubist Pharmaceuticals Inc | 10% Owner | Buy | $5.0M (1,180,983 @ $4.25) |
| Dec 7, 2011 | Cubist Pharmaceuticals Inc | 10% Owner | Buy | $18.3M (4,306,129 @ $4.25) |
| Dec 7, 2011 | FRD Acquisition Corp | 10% Owner | Buy | $18.3M (4,306,129 @ $4.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.